Aclarion (ACONW) Research & Development (2021 - 2026)
Aclarion (ACONW) reported Research & Development of $315417.0 for Q1 2026, up 59.15% on a YoY basis from $198190.0 in Q1 2025, and up 19.87% quarter-over-quarter from $263130.0 in Q4 2025.
Aclarion (ACONW) Research & Development (2021 - 2026) Analysis & Trends
Aclarion has reported Research & Development for 6 years, with the latest figure at $315417.0 in Q1 2026.
- For the quarter ending Q1 2026, Research & Development rose 59.15% year-over-year to $315417.0; the trailing twelve-month figure through Mar 2026 stood at $1.2 million (up 35.75% YoY), and the FY2025 full-year result was $1.0 million, up 16.32% from the prior year.
- Research & Development for Q1 2026 stood at $315417.0, up from $263130.0 in the prior quarter.
- The five-year high for Research & Development was $353226.0 in Q2 2022, with the low at $195797.0 in Q3 2024.
- Historically, Research & Development has averaged $245841.4 across 5 years, with a median of $239042.0 in 2024.
- Annual changes were most pronounced in 2022 — Research & Development surged 117.08% — and 2023, when it slumped 31.86%.
- Aclarion's Research & Development stood at $218997.0 in 2022, then advanced by 0.77% to $220679.0 in 2023, then advanced by 14.11% to $251826.0 in 2024, then gained by 4.49% to $263130.0 in 2025, then advanced by 19.87% to $315417.0 in 2026.
- The last three Research & Development figures came in at $315417.0 (Q1 2026), $263130.0 (Q4 2025), and $302037.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | 208.32 Mn |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | - |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | 67.77 Mn |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | 30.34 Mn |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | 56.85 Mn |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | 39.11 Mn |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | 18.37 Mn |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | - |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | 21.52 Mn |
| 10 | Aclarion | - | - | 3,750.00 | 315,417.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 315,417.00 |
| Dec 31, 2025 | 263,130.00 |
| Sep 30, 2025 | 302,037.00 |
| Jun 30, 2025 | 270,434.00 |
| Mar 31, 2025 | 198,190.00 |
| Dec 31, 2024 | 251,826.00 |
| Sep 30, 2024 | 195,797.00 |
| Jun 30, 2024 | 202,102.00 |
| Mar 31, 2024 | 239,042.00 |
| Dec 31, 2023 | 220,679.00 |
| Sep 30, 2023 | 198,252.00 |
| Jun 30, 2023 | 250,006.00 |
| Mar 31, 2023 | 204,399.00 |
| Dec 31, 2022 | 218,997.00 |
| Sep 30, 2022 | 290,966.00 |
| Jun 30, 2022 | 353,226.00 |
| Mar 31, 2022 | 204,803.00 |
| Dec 31, 2021 | 182,101.00 |
| Sep 30, 2021 | 275,284.00 |
| Jun 30, 2021 | 162,714.00 |